<DOC>
	<DOCNO>NCT01830283</DOCNO>
	<brief_summary>To investigate safety , immunogenicity immune effect Varicella vaccine 2nd dose vaccination Chao yang district , Bei jing , since 2nd varicella vaccination promote Beijing Center Disease Control Prevention November , 2012 .</brief_summary>
	<brief_title>The Safety , Immunogenicity Immune Effect Research Varicella Vaccine After 2nd Dose Vaccination</brief_title>
	<detailed_description>`` Breakthrough '' varicella case varicella case monitor evaluate protective effective large population . Make basic evaluation safety two dose varicella vaccination Monitoring Varicella virus origin virus type illness case Chao yang district Make evaluation healthy cost reduce varicella emergency vaccination large number varicella case occur .</detailed_description>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Participants 412 year old Participants good healthy determine medical history , physical examination , clinical judgment investor Having fever ( axillary temperature ＞37.0℃ ) enrollment ; Having disease history seizure , brain mental disease vaccination history allergy convulsion ; Antibiotics allergy ; Having problem intramuscular injection thrombocytopenia blood coagulation disorder ; Having immunodeficiency immunosuppression therapy , radiation therapy ; Having respiratory disease , acute infection , chronic disease HIV infection ; Having systemic skin rash , skin tinea , herpes ; Chronic liver kidney disease ; Heart disease , severe hypertension ; Have receive whole blood , plasma immunoglobulin therapy 3 month enrollment ; Have receive vaccination 7 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>